Use of Prescription Antiobesity Drugs in the United States-Reference-Cited by-同舟云学术

Use of Prescription Antiobesity Drugs in the United States

Published:2013-09-09 Issue:12 Volume:33 Page:1299-1307
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Hampp Christian¹,Kang Elizabeth M.¹,Borders-Hemphill Vicky²

Affiliation:

1. Division of Epidemiology-I; Office of Pharmacovigilance and Epidemiology; Office of Surveillance and Epidemiology; Center for Drug Evaluation and Research; U.S. Food and Drug Administration; Silver Spring Maryland

2. Division of Medication Error Prevention and Analysis; Office of Medication Error Prevention and Risk Management; Office of Surveillance and Epidemiology; Center for Drug Evaluation and Research; U.S. Food and Drug Administration; Silver Spring Maryland

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1342/fullpdf

Reference17 articles.

1. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010;Flegal;JAMA,2012

2. Obesity and severe obesity forecasts through 2030;Finkelstein;Am J Prev Med,2012

3. The effect of obesity on health outcomes;Dixon;Mol Cell Endocrinol,2010

4. Annual medical spending attributable to obesity: payer-and service-specific estimates;Finkelstein;Health Aff (Millwood),2009

5. The medical care costs of obesity: an instrumental variables approach;Cawley;J Health Econ,2012

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to Obesity Treatment in Primary Care;JAMA Internal Medicine;2024-07-01

2. Comparison of the Efficacy of Anti-Obesity Medications in Real-World Practice;Drug Design, Development and Therapy;2024-03

3. Understanding cross-data dynamics of individual and social/environmental factors through a public health lens: explainable machine learning approaches;Frontiers in Public Health;2023-10-26

4. Potential drug-drug interactions with phentermine among long-term phentermine consumers: A retrospective analysis;South African Medical Journal;2023-08-03

5. Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine–Topiramate to Prevent Exposure During Pregnancy;Annals of Internal Medicine;2023-04